Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333423 was updated to Taoyuan, Taiwan, 333423 in the locations list. The postal code remains 333423.
    Difference
    0.0%
    Check dated 2026-05-07T22:22:30.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Study availability was updated by adding and removing certain clinical trial sites/locations, including changes to specific cities and administrative regions (e.g., in Chile, Finland, and Romania). The record also reflects an updated data-sharing detail setup around providing anonymized participant data under the study’s IPD plan.
    Difference
    0.8%
    Check dated 2026-04-23T21:54:06.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T12:53:14.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T19:37:54.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; no user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-11T18:33:06.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page shows a minor site maintenance update: addition of Revision: v3.4.2 and removal of the older funding-related note (Revision: v3.4.1); no changes to core study details, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T09:56:06.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.